While the singular administration of an NPY1R agonist or Ketamine did not produce significant results in our object-in-place task, the literature suggests that NPY and its agonists have the capacity to ameliorate spatial memory deficits in rodent models mimicking Alzheimer’s disease symptoms [63]. The gene discussed is NPY; the disease is early-onset autosomal dominant Alzheimer disease.